£44.44

CRC Press Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)

Price data last checked 63 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 28 days • 28 data points (No recent data available)

Historical
Generating forecast...
£44.44 £42.22 £43.11 £44.00 £44.88 £45.77 £46.66 25 January 2026 31 January 2026 07 February 2026 14 February 2026 21 February 2026

Price Distribution

Price distribution over 28 days • 1 price levels

Days at Price
28 days 0 7 14 21 28 £44 Days at Price

Price Analysis

Most common price: £44 (28 days, 100.0%)

Price range: £44 - £44

Price levels: 1 different prices over 28 days

Description

Real-world evidence (RWE) has been at the forefront of pharmaceutical innovations. It plays an important role in transforming drug development from a process aimed at meeting regulatory expectations to an operating model that leverages data from disparate sources to aid business, regulatory, and healthcare decision making. Despite its many benefits, there is no single book systematically covering the latest development in the field. Written specifically for pharmaceutical practitioners, Real-World Evidence in Drug Development and Evaluation, presents a wide range of RWE applications throughout the lifecycle of drug product development. With contributions from experienced researchers in the pharmaceutical industry, the book discusses at length RWE opportunities, challenges, and solutions. Features Provides the first book and a single source of information on RWE in drug development Covers a broad array of topics on outcomes- and value-based RWE assessments Demonstrates proper Bayesian application and causal inference for real-world data (RWD) Presents real-world use cases to illustrate the use of advanced analytics and statistical methods to generate insights Offers a balanced discussion of practical RWE issues at hand and technical solutions suitable for practitioners with limited data science expertise

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
29 August 2022
Listed Since
03 June 2022

Barcode

No barcode data available

Similar Products You Might Like

Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)
99% match

Real-World Evidence in Drug Development and Evaluation (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£119.60 23 Feb 2026
Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)
96% match

Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)

Chapman and Hall/CRC

£42.72 01 Mar 2026
Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)
95% match

Real-World Evidence in a Patient-Centric Digital Era (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£97.00 09 Mar 2026
Bayesian Methods in Pharmaceutical Research (Chapman & Hall/CRC Biostatistics Series)
95% match

Bayesian Methods in Pharmaceutical Research (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£48.27 15 Feb 2026
Springer - Real-World Evidence in Medical Product Development
95% match

Springer - Real-World Evidence in Medical Product Development

Springer

£102.00 23 Feb 2026
CRC Press Bayesian Methods in Pharmaceutical Research Book
94% match

CRC Press Bayesian Methods in Pharmaceutical Research Book

CRC Press

£102.77 20 Apr 2026
Exposure-Response Modeling: Methods and Practical Implementation (Chapman & Hall/CRC Biostatistics Series)
94% match

Exposure-Response Modeling: Methods and Practical Implementation (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£48.33 22 Feb 2026
Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting (Chapman & Hall/CRC Biostatistics Series)
94% match

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£48.33 20 Feb 2026
Causal Inference in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)
94% match

Causal Inference in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)

Chapman and Hall/CRC

£93.91 08 Mar 2026
Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)
93% match

Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£60.89 06 Mar 2026
Innovative Statistics in Regulatory Science (Chapman & Hall/CRC Biostatistics Series)
93% match

Innovative Statistics in Regulatory Science (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£97.00 09 Mar 2026
Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)
93% match

Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£75.00 27 Feb 2026
Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies (Chapman & Hall/CRC Biostatistics Series)
93% match

Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£42.31 28 Feb 2026
Biomarker Analysis in Clinical Trials with R (Chapman & Hall/CRC Biostatistics Series)
93% match

Biomarker Analysis in Clinical Trials with R (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£45.76 15 Feb 2026
Multiple Testing Problems in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)
93% match

Multiple Testing Problems in Pharmaceutical Statistics (Chapman & Hall/CRC Biostatistics Series)

Chapman and Hall/CRC

£45.07 07 Mar 2026
Case Studies in Innovative Clinical Trials (Chapman & Hall/CRC Biostatistics Series)
93% match

Case Studies in Innovative Clinical Trials (Chapman & Hall/CRC Biostatistics Series)

£128.80 11 Jan 2026
Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies (Chapman & Hall/CRC Biostatistics Series)
93% match

Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£110.95 25 Feb 2026
Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)
93% match

Multiregional Clinical Trials for Simultaneous Global New Drug Development (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£115.00 27 Feb 2026
Innovative Methods for Rare Disease Drug Development (Chapman & Hall/CRC Biostatistics Series)
93% match

Innovative Methods for Rare Disease Drug Development (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£115.22 24 Feb 2026
Biomarker Analysis in Clinical Trials with R (Chapman & Hall/CRC Biostatistics Series)
93% match

Biomarker Analysis in Clinical Trials with R (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£94.66 27 Feb 2026
Medical Product Safety Evaluation: Biological Models and Statistical Methods (Chapman & Hall/CRC Biostatistics Series)
93% match

Medical Product Safety Evaluation: Biological Models and Statistical Methods (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£62.35 02 Mar 2026
Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting: 67 (Chapman & Hall/CRC Biostatistics Series)
93% match

Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting: 67 (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£85.00 08 Mar 2026
Economic Evaluation of Cancer Drugs: Using Clinical Trial and Real-World Data (Chapman & Hall/CRC Biostatistics)
93% match

Economic Evaluation of Cancer Drugs: Using Clinical Trial and Real-World Data (Chapman & Hall/CRC Biostatistics)

CRC Press

£36.74 28 Jan 2026
Interval-Censored Time-to-Event Data: Methods and Applications (Chapman & Hall/CRC Biostatistics Series)
93% match

Interval-Censored Time-to-Event Data: Methods and Applications (Chapman & Hall/CRC Biostatistics Series)

Chapman and Hall/CRC

£49.84 07 Mar 2026